1st Department of Medicine-Cardioangiology, Charles University, Faculty of Medicine and University Hospital in Hradec Králové, Sokolská 581, Hradec Králové, Czech Republic.
Department of Medical Biophysics, Faculty of Medicine in Hradec Kralove, Charles University, Prague, Czech Republic.
ESC Heart Fail. 2022 Aug;9(4):2249-2258. doi: 10.1002/ehf2.13759. Epub 2022 Apr 7.
Acute heart failure represents a medical condition with very high mortality. Accurate risk stratification can help physicians to improve the health care about these patients. The aim of our study was to characterize real-life patients admitted for acute heart failure in a specific region with one tertiary medical centre and to describe risk factors of short-term and long-term mortality.
We performed a retrospective analysis of patients admitted from January 2017 to December 2017 to Department of cardiology of the tertiary medical centre University Hospital in Hradec Kralove. We identified 385 patients admitted for acute heart failure to the standard care and intensive care unit. The median of age was 74 years (IQR 67.5-80) and 34% of patients were female. Hospital admission was due to de novo heart failure in 222 (57.7%) patients. The most common comorbidities were arterial hypertension (77.7%), dyslipidaemia (67.3%) and coronary artery disease (63.1%). Coronary artery disease (52.7% of cases) and valve disease (28.1% of cases) were the most common aetiologies of heart failure. The all-cause in-hospital mortality was 12.7%, 30-day mortality was 14.6% and 1 year mortality was 34%. Among risk factors of in-hospital mortality, the most significant factors were haemodialysis during the hospitalization [odds ratio (OR) 15.82, 95% confidence interval (CI) 2.96-84.57, P = 0.0008], chronic heart failure (OR 4.27, 95% CI 1.66-11.03, P = 0.001) and STEMI as a precipitating factor of heart failure (OR 4.19, 95% CI 1.23-14.25, P = 0.023). Haemodialysis during the hospitalization (OR 4.28, 95% CI 1.17-15.61, P = 0.025) and the comorbidity depression and anxiety (OR 3.49, 95% CI 1.45-8.39, P = 0.005) were the most significant risk factors of long-term mortality.
Our study confirms very high mortality rates among patients with acute heart failure underlying poor prognosis of these patients. Comorbidities (peripheral artery disease, atrial fibrillation, chronic heart failure and depression and anxiety), precipitating factors of heart failure (myocardial infarction with ST segment elevation), complications occurring during the hospitalization (acute kidney injury, pulmonary ventilation for respiratory failure and haemodialysis) and the age of patients should be included in the risk stratification of in-hospital, 30 day and 1 year mortality.
急性心力衰竭是一种死亡率非常高的医疗状况。准确的风险分层可以帮助医生改善这些患者的医疗护理。我们研究的目的是描述一个特定地区(一家三级医疗中心)因急性心力衰竭入院的真实患者,并描述短期和长期死亡率的危险因素。
我们对 2017 年 1 月至 2017 年 12 月在哈雷迪采大学医院心内科接受标准治疗和重症监护病房治疗的急性心力衰竭患者进行了回顾性分析。我们确定了 385 例因急性心力衰竭入院的患者。患者的中位年龄为 74 岁(IQR 67.5-80),34%的患者为女性。新发心力衰竭导致医院入院 222 例(57.7%)。最常见的合并症为动脉高血压(77.7%)、血脂异常(67.3%)和冠状动脉疾病(63.1%)。冠状动脉疾病(52.7%的病例)和瓣膜疾病(28.1%的病例)是心力衰竭的最常见病因。全因院内死亡率为 12.7%,30 天死亡率为 14.6%,1 年死亡率为 34%。在院内死亡率的危险因素中,最显著的因素是住院期间血液透析[比值比(OR)15.82,95%置信区间(CI)2.96-84.57,P=0.0008]、慢性心力衰竭(OR 4.27,95%CI 1.66-11.03,P=0.001)和 STEMI 作为心力衰竭的诱发因素(OR 4.19,95%CI 1.23-14.25,P=0.023)。住院期间血液透析(OR 4.28,95%CI 1.17-15.61,P=0.025)和共病抑郁和焦虑(OR 3.49,95%CI 1.45-8.39,P=0.005)是长期死亡率的最显著危险因素。
我们的研究证实,急性心力衰竭患者的死亡率非常高,这些患者的预后较差。合并症(外周动脉疾病、心房颤动、慢性心力衰竭和抑郁焦虑)、心力衰竭的诱发因素(ST 段抬高型心肌梗死)、住院期间发生的并发症(急性肾损伤、呼吸衰竭的肺部通气和血液透析)以及患者年龄应纳入院内、30 天和 1 年死亡率的风险分层。